ConductScience.org, home

Paper401808

Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.

Helting TB and 1 other. J Biol Chem, 1977. Cited by 141 papers, by iCite.

Cite this record

ConductScience Library. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments. Papers, record 401808. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/401808

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.
PubMed
Journal
J Biol Chem
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
141
iCite
Relative citation ratio, by iCite
3.86
iCite
Revised in PubMed
2021-02-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Helting TBT B
2Zwisler OO

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tetanus ToxinMajor topic
Amino Acids
Animals
Biological Assay
Immune Sera
Immunodiffusion
Macromolecular Substances
Mice
Molecular Weight
Papain
Peptide Fragments

Source PubMed

Download CSV of topics

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.

PMIDTitleJournalYearIn PapersSource
37663798Phage display technology for fabricating a recombinant monoclonal ScFv antibody against tetanus toxin.Toxicol Res (Camb)2023https://conductscience.org/library/papers/37663798PubMed
35745675Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35745675PubMed
34680132Confocal Endomicroscopy of Neuromuscular Junctions Stained with Physiologically Inert Protein Fragments of Tetanus Toxin.Biomolecules2021https://conductscience.org/library/papers/34680132PubMed
31721050Contribution of Fc fragment of monoclonal antibodies to tetanus toxin neutralization.Neurotox Res2020https://conductscience.org/library/papers/31721050PubMed
30240216Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.Mol Pharm2018https://conductscience.org/library/papers/30240216PubMed
27626445Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.Toxins (Basel)2016https://conductscience.org/library/papers/27626445PubMed
27348002Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys.Toxins (Basel)2016https://conductscience.org/library/papers/27348002PubMed
25868452Engineered nanoparticles mimicking cell membranes for toxin neutralization.Adv Drug Deliv Rev2015https://conductscience.org/library/papers/25868452PubMed
24678405Recombinant human antibody fragment against tetanus toxoid produced by phage display.Eur J Microbiol Immunol (Bp)2014https://conductscience.org/library/papers/24678405PubMed
24395625Molecular imaging detects impairment in the retrograde axonal transport mechanism after radiation-induced spinal cord injury.Mol Imaging Biol2014https://conductscience.org/library/papers/24395625PubMed
23949787Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates.Glycoconj J2013https://conductscience.org/library/papers/23949787PubMed
19757026Multimeric bivalent immunogens from recombinant tetanus toxin HC fragment, synthetic hexasaccharides, and a glycopeptide adjuvant.Glycoconj J2010https://conductscience.org/library/papers/19757026PubMed
19730859Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.Cancer Immunol Immunother2010https://conductscience.org/library/papers/19730859PubMed
16785105Re-engineering the target specificity of Clostridial neurotoxins - a route to novel therapeutics.Neurotox Res2006https://conductscience.org/library/papers/16785105PubMed
14675488Emerging Applications of Bacterial Spores in Nanobiotechnology.J Nanobiotechnology2003https://conductscience.org/library/papers/14675488PubMed
11591673Surface display of recombinant proteins on Bacillus subtilis spores.J Bacteriol2001https://conductscience.org/library/papers/11591673PubMed
10992478Protective antigen-mediated antibody response against a heterologous protein produced in vivo by Bacillus anthracis.Infect Immun2000https://conductscience.org/library/papers/10992478PubMed
10456940Cell surface-exposed tetanus toxin fragment C produced by recombinant Bacillus anthracis protects against tetanus toxin.Infect Immun1999https://conductscience.org/library/papers/10456940PubMed
9529093A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor.Infect Immun1998https://conductscience.org/library/papers/9529093PubMed
8757849Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin.Infect Immun1996https://conductscience.org/library/papers/8757849PubMed

See all 51 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/401808

GET https://conductscience.org/api/papers/v1/401808/cited_by?page=2